Position in IRWD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$149,577
New position
Shares Held
35,529
first reported quarter
Ownership
0.022%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#119
of 212 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $42,596,492 across 20 Drug Manufacturers - Specialty & Generic names. IRWD ranks #20 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
392,480 | $13,297,221 | |
| 2 | ZTS |
Zoetis Inc.
|
116,123 | $8,344,597 | |
| 3 | HLN |
Haleon plc
|
504,080 | $4,703,065 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
6,217 | $3,368,556 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
51,671 | $3,304,360 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
17,951 | $3,025,461 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
71,842 | $1,151,626 | |
| 8 | VTRS |
Viatris Inc
|
61,364 | $974,459 |
All Filings in IRWD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $149,577 | 35,529 | Shares | Defined | 2026-07-28 | |
| No filing history on record for this holder in this stock. | ||||||